Showing results (151-160 of 254) with videos related to
Sort By:
Pageof 26
AIDS (London, England)|June 1, 1988
Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibitionJ Goudsmit, C A Boucher, R H Meloen, et al.AIDS (London, England)|September 1, 1995
Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study GroupE Fernández-Cruz, J M Lang, J Frissen, et al.Radiation Medicine|October 1, 1986
High-risk subgroup of inferior myocardial infarction: importance of anterior wall motion and right ventricular functionT Nishimura, T Yasuda, H K Gold, et al.The American Journal of Cardiology|March 1, 1986
Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery diseaseS Homma, R J Callahan, B Ameer, et al.The American Journal of Cardiology|June 1, 1985
Increased thallium lung uptake after exercise in isolated left anterior descending coronary artery diseaseP Liu, M Kiess, R D Okada, et al.The Journal of Infectious Diseases|July 7, 2000
Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333A D Sevin, V DeGruttola, M Nijhuis, et al.Nederlands Tijdschrift Voor Geneeskunde|March 5, 1999
[Vertical HIV-I-transmission. I. Risk and prevention in pregnancy]J M Orendi, K Boer, A M van Loon, et al.Nuclear Medicine Communications|December 1, 1986
Incidence, severity and clinical course of right ventricular involvement after acute inferior myocardial infarction; assessment by sequential 99Tcm-pyrophosphate scan and gated blood pool scanT Nishimura, T Yasuda, H K Gold, et al.Circulation Research|October 1, 1988
Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardiumD D Miller, J B Gill, E Livni, et al.Journal of Virology|January 1, 1997
Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical modelN I Stilianakis, C A Boucher, M D De Jong, et al.Pageof 26